Maximillian von Eynatten

Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

Simke W. Waijer, Di Xie, Silvio E. Inzucchi et al. · Journal of the American Heart Association · 2020 · 74 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Vlado Perkovic, Robert D. Toto, Mark E. Cooper et al. · Diabetes Care · 2020 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double‐blind 1‐year extension study

T Haak, Thomas Meinicke, Russell Jones et al. · International Journal of Clinical Practice · 2013 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17